[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![CorleoneDon77 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1577382889104318472.png) DonCorleone77 [@CorleoneDon77](/creator/twitter/CorleoneDon77) on x 5455 followers
Created: 2025-06-11 00:04:42 UTC

$ARGX Argenx presents new Efgartigimod data at EULAR 2025

argenx SE "announced the presentation of positive results from Phase X studies evaluating VYVGART in Sjogren's disease and idiopathic inflammatory myopathies at the European Congress of Rheumatology, EULAR 2025, from June XX - XX in Barcelona, Spain. argenx also announced that the FDA has granted efgartigimod Fast Track designation for the treatment of primary Sjogren's disease."


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1932589775187554507/c:line.svg)

**Related Topics**
[spain](/topic/spain)
[barcelona](/topic/barcelona)
[$argx](/topic/$argx)

[Post Link](https://x.com/CorleoneDon77/status/1932589775187554507)